JP Morgan Chase
LENZ

JP Morgan Chase’s LENZ Therapeutics LENZ Stock Holding History

JP Morgan Chase’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$90.2K Buy
10,883
+1,418
+15% +$19.9K ﹤0.01% 5886
2025
Q4 		$151K Sell
9,465
-1,757
-16% -$51.2K ﹤0.01% 5667
2025
Q3 		$523K Buy
11,222
+861
+8% +$31.7K ﹤0.01% 5003
2025
Q2 		$304K Buy
10,361
+2,310
+29% +$62.8K ﹤0.01% 5022
2025
Q1 		$207K Sell
8,051
-291
-3% -$7.17K ﹤0.01% 5225
2024
Q4 		$241K Buy
8,342
+2,643
+46% +$80.6K ﹤0.01% 5398
2024
Q3 		$135K Buy
5,699
+279
+5% +$6.19K ﹤0.01% 5581
2024
Q2 		$93.7K Buy
5,420
+3,738
+222% +$65.3K ﹤0.01% 5543
2024
Q1 		$37.6K Sell
1,682
-913
-35% -$19K ﹤0.01% 6040
2023
Q4 		$47.6K Sell
2,595
-1,504
-37% -$24.8K ﹤0.01% 6014
2023
Q3 		$71.2K Buy
4,099
+691
+20% +$12K ﹤0.01% 5673
2023
Q2 		$62K Buy
3,408
+3,198
+1,523% +$63.9K ﹤0.01% 5659
2023
Q1 		$4K Sell
210
-349
-62% -$5.64K ﹤0.01% 6311
2022
Q4 		$13K Sell
559
-337
-38% -$7.81K ﹤0.01% 5987
2022
Q3 		$20K Buy
896
+175
+24% +$4.17K ﹤0.01% 5809
2022
Q2 		$14K Sell
721
-2,211
-75% -$49.3K ﹤0.01% 5977
2022
Q1 		$105K Buy
2,932
+1,311
+81% +$82K ﹤0.01% 5484
2021
Q4 		$141K Buy
1,621
+732
+82% +$60.6K ﹤0.01% 5533
2021
Q3 		$102K Buy
+889
New +$132K ﹤0.01% 5557

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

JP Morgan Chase's LENZ Position: Q1 2026 in Review

JP Morgan Chase increased its LENZ Therapeutics (LENZ) stake by 15% in Q1 2026, buying an estimated $19.9K and bringing the position to 10,883 shares worth $90.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5886.

JP Morgan Chase first reported a position in LENZ in Q3 2021 and has held it in 19 quarters since. The position peaked at $523K in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • JP Morgan Chase held 10,883 shares of LENZ Therapeutics worth $90.2K as of Q1 2026.
  • JP Morgan Chase bought 1,418 LENZ Therapeutics shares in Q1 2026, an estimated $19.9K.
  • LENZ Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5886 holding.
  • JP Morgan Chase first reported a position in LENZ Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • JP Morgan Chase's LENZ Therapeutics position peaked at $523K in Q3 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.